Faria, Vanda

A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety

Furmark, T., Appel, L., Henningsson, S., Åhs, F., Faria, V., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., et al. (2008) · The Journal of Neuroscience

Pain Management and Placebo EffectNeurotransmitter Receptor Influence on Behavior

Cited by 210

Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder

Faria, V., Appel, L., Åhs, F., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., Pich, E. M., Jacobsson, E., et al. (2012) · Neuropsychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPain Management and Placebo Effect

Cited by 73

Do you believe it? verbal suggestions influence the clinical and neural effects of escitalopram in social anxiety disorder: a randomized trial

Faria, V., Gingnell, M., Hoppe, J. M., Hjorth, O., Alaie, I., Frick, A., Hultberg, S., Wahlstedt, K., Engman, J., Månsson, K. N. T., et al. (2017) · EBioMedicine

Pain Management and Placebo EffectAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 70

Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial

Hjorth, O. R., Frick, A., Gingnell, M., Hoppe, J. M., Faria, V., Hultberg, S., Alaie, I., Månsson, K. N. T., Rosén, J., Reis, M., et al. (2021) · Translational Psychiatry

Neurotransmitter Receptor Influence on BehaviorAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 46

Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial

Gingnell, M., Frick, A., Engman, J., Alaie, I., Björkstrand, J., Faria, V., Carlbring, P., Andersson, G., Reis, M., Larsson, E.-M., et al. (2016) · British Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesDigital Mental Health Interventions

Cited by 44

Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder

Faria, V., Åhs, F., Appel, L., Linnman, C., Bani, M., Bettica, P., Pich, E. M., Fredrikson, M., & Furmark, T. (2014) · The International Journal of Neuropsychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 37

Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy

Hjorth, O., Frick, A., Gingnell, M., Engman, J., Björkstrand, J., Faria, V., Alaie, I., Carlbring, P., Andersson, G., Jonasson, M., et al. (2022) · Translational Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 13

Generative AI in healthcare: challenges to patient agency and ethical implications

Holmes, S. A., Faria, V., & Moulton, E. A. (2025) · Frontiers in Digital Health

Artificial Intelligence in Healthcare and EducationEthics and Social Impacts of AI

Cited by 4

Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters

Furmark, T., Wahlstedt, K., & Faria, V. (2025) · Frontiers in Psychology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPain Management and Placebo Effect

Cited by 1